Page last updated: 2024-08-24

3-iodobenzylguanidine and vorinostat

3-iodobenzylguanidine has been researched along with vorinostat in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (66.67)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Dubois, SG; Geier, EG; Giacomini, KM; Haas-Kogan, DA; Itsara, M; Matthay, KK; More, SS; Mueller, S; Seo, Y; Tadano, MK; Vanbrocklin, HF; Weiss, WA; Yang, X	1
Chen, E; Cohn, SL; Courtier, J; Czarnecki, S; DuBois, SG; Geier, E; Giacomini, K; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Hawkins, R; Jackson, H; Marachelian, A; Matthay, KK; Park, JR; Shimada, H; Tsao-Wei, D; Villablanca, JG; Weiss, B; Yang, X; Yanik, GA	1
Berkovich, R; Cohn, SL; Czarnecki, S; DuBois, SG; Goldsmith, KC; Goodarzian, F; Granger, MM; Groshen, S; Haas-Kogan, DA; Irwin, MS; Ji, L; Marachelian, A; Maris, JM; Matthay, KK; Mosse, YP; Park, JR; Pinto, N; Shamirian, A; Shimada, H; Shusterman, S; Tsao-Wei, D; Twist, CJ; Villablanca, JG; Vo, KT; Weiss, B; Yanik, GA	1

Trials

2 trial(s) available for 3-iodobenzylguanidine and vorinostat

Article	Year
Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jun-15, Volume: 21, Issue:12 Topics: 3-Iodobenzylguanidine; Acetylation; Adolescent; Adult; Aged; Child; Child, Preschool; Drug Monitoring; Female; Histones; Humans; Hydroxamic Acids; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiation-Sensitizing Agents; Treatment Outcome; Vorinostat; Young Adult	2015
Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 11-01, Volume: 39, Issue:31 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infant; Irinotecan; Male; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine; Vorinostat; Young Adult	2021

Article

Year

Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Jun-15, Volume: 21, Issue:12

Topics: 3-Iodobenzylguanidine; Acetylation; Adolescent; Adult; Aged; Child; Child, Preschool; Drug Monitoring; Female; Histones; Humans; Hydroxamic Acids; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Recurrence, Local; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiation-Sensitizing Agents; Treatment Outcome; Vorinostat; Young Adult

2015

Randomized Phase II Trial of MIBG Versus MIBG, Vincristine, and Irinotecan Versus MIBG and Vorinostat for Patients With Relapsed or Refractory Neuroblastoma: A Report From NANT Consortium.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 11-01, Volume: 39, Issue:31

Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Humans; Infant; Irinotecan; Male; Neoplasm Recurrence, Local; Neuroblastoma; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Vincristine; Vorinostat; Young Adult

2021

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and vorinostat

Article	Year
Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems. Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-15, Volume: 17, Issue:8 Topics: 3-Iodobenzylguanidine; Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Transplantation, Heterologous; Vorinostat	2011

Article

Year

Vorinostat increases expression of functional norepinephrine transporter in neuroblastoma in vitro and in vivo model systems.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2011, Apr-15, Volume: 17, Issue:8

Topics: 3-Iodobenzylguanidine; Animals; Blotting, Western; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Nude; Neoplasms, Experimental; Neuroblastoma; Norepinephrine Plasma Membrane Transport Proteins; Radiopharmaceuticals; Reverse Transcriptase Polymerase Chain Reaction; Tissue Distribution; Transplantation, Heterologous; Vorinostat

2011